Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Mouse Laminin alpha 1 ELISA Kit (AC2713)
Cat.#: ASET-1302
Specifications
Description Mouse Laminin alpha 1 ELISA Kit allows for the in vitro quantitative determination of mouse Laminin alpha 1 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.469 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.781-50 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1153 Human Plexin A4 ELISA Kit (AC2564) Quantitative inquiry ASET-2361 Human Leptin ELISA Kit (AC3772) Quantitative inquiry ASET-1242 Mouse Wnt6 ELISA Kit (AC2653) Quantitative inquiry ASET-1232 Human NENF ELISA Kit (AC2643) Quantitative inquiry ASET-1363 Rat ACTH ELISA Kit (AC2774) Quantitative inquiry ASET-2275 Human Calbindin ELISA Kit (AC3686) Quantitative inquiry ASET-2319 Human 5HT7 Receptor ELISA Kit (AC3730) Quantitative inquiry ASET-2122 Human COMT ELISA Kit (AC3533) Quantitative inquiry ASET-1257 Mouse Calbindin ELISA Kit (AC2668) Quantitative inquiry ASET-1602 Mouse SYN2 ELISA Kit (AC3013) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket